We provide you with 20 years of free, institutional-grade data for ETNB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ETNB. Explore the full financial landscape of ETNB stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$899,220
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Martins Ryan | Sale | -7,680 | $9.16 | $70,349 | 2025-08-05 |
| Sarena Francis Willard | Sale | -6,185 | $9.16 | $56,655 | 2025-08-05 |
| PALEKAR ROHAN | Sale | -55,836 | $9.16 | $511,458 | 2025-08-05 |
| Le-Nguyen Quoc | Sale | -522 | $9.16 | $4,782 | 2025-08-05 |
| Le-Nguyen Quoc | Sale | -7,680 | $9.16 | $70,349 | 2025-08-05 |
| Mansbach Harry H | Sale | -7,680 | $9.16 | $70,349 | 2025-08-05 |
| Le-Nguyen Quoc | Sale | -10,461 | $11.02 | $115,280 | 2025-07-17 |
| Le-Nguyen Quoc | Sale | -534 | $9.62 | $5,137 | 2025-06-13 |
| Le-Nguyen Quoc | Sale | -8,498 | $9.62 | $81,751 | 2025-06-13 |
| Mansbach Harry H | Sale | -8,498 | $9.62 | $81,751 | 2025-06-13 |
| Martins Ryan | Sale | -8,498 | $9.62 | $81,751 | 2025-06-13 |
| Le-Nguyen Quoc | Sale | -15,329 | $5.95 | $91,208 | 2025-04-17 |
| Martins Ryan | Sale | -780 | $10.57 | $8,245 | 2025-02-19 |
| Mansbach Harry H | Sale | -1,050 | $10.57 | $11,099 | 2025-02-19 |
| PALEKAR ROHAN | Sale | -3,249 | $10.57 | $34,342 | 2025-02-19 |
| Le-Nguyen Quoc | Grant, award...etc | 14,750 | 2025-02-19 | ||
| Le-Nguyen Quoc | Sale | -1,050 | $10.57 | $11,099 | 2025-02-19 |
| Mansbach Harry H | Sale | -3,817 | $11.41 | $43,552 | 2025-02-11 |
| Martins Ryan | Sale | -3,828 | $11.41 | $43,677 | 2025-02-11 |
| PALEKAR ROHAN | Sale | -8,946 | $11.41 | $102,074 | 2025-02-11 |
| Le-Nguyen Quoc | Sale | -3,793 | $11.41 | $43,278 | 2025-02-11 |
| Martins Ryan | Sale | -3,338 | $9.6 | $32,045 | 2025-02-04 |
| Martins Ryan | Grant, award...etc | 80,000 | 2025-02-04 | ||
| Le-Nguyen Quoc | Sale | -3,338 | $9.6 | $32,045 | 2025-02-04 |
| Le-Nguyen Quoc | Grant, award...etc | 80,000 | 2025-02-04 | ||
| Mansbach Harry H | Sale | -3,338 | $9.6 | $32,045 | 2025-02-04 |
| Mansbach Harry H | Grant, award...etc | 80,000 | 2025-02-04 | ||
| PALEKAR ROHAN | Sale | -9,598 | $9.6 | $92,141 | 2025-02-04 |
| PALEKAR ROHAN | Grant, award...etc | 412,000 | 2025-02-04 | ||
| Sarena Francis Willard | Grant, award...etc | 53,750 | 2025-02-04 | ||
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 5,714,285 | $8.75 | 2025-02-03 | |
| McWherter Charles | Open Market Purchase | 15,000 | $6.55 | 2025-01-23 | |
| Le-Nguyen Quoc | Sale | -10,963 | $6.49 | $71,150 | 2025-01-17 |
| Mansbach Harry H | Grant, award...etc | -95,000 | 2024-12-16 | ||
| Le-Nguyen Quoc | Grant, award...etc | -95,000 | 2024-12-16 | ||
| Martins Ryan | Grant, award...etc | -95,000 | 2024-12-16 | ||
| PALEKAR ROHAN | Open Market Purchase | 5,000 | $7.89 | 2024-12-10 | |
| McWherter Charles | Open Market Purchase | 10,000 | $8 | 2024-12-09 | |
| PALEKAR ROHAN | Open Market Purchase | 10,000 | $8.35 | 2024-11-25 | |
| Le-Nguyen Quoc | Sale | -27,955 | $8.12 | $226,995 | 2024-11-01 |
| Mansbach Harry H | Sale | -5,352 | $8.46 | $45,278 | 2024-09-10 |
| Martins Ryan | Sale | -3,212 | $8.46 | $27,174 | 2024-09-10 |
| Le-Nguyen Quoc | Sale | -5,352 | $8.46 | $45,278 | 2024-09-10 |
| Le-Nguyen Quoc | Sale | -1,046 | $8.04 | $8,410 | 2024-08-19 |
| PALEKAR ROHAN | Sale | -4,601 | $8.04 | $36,992 | 2024-08-19 |
| Mansbach Harry H | Sale | -1,046 | $8.04 | $8,410 | 2024-08-19 |
| Martins Ryan | Sale | -777 | $8.04 | $6,247 | 2024-08-19 |
| Sarena Francis Willard | Grant, award...etc | 25,000 | 2024-08-07 | ||
| PALEKAR ROHAN | Sale | -52,718 | $10.91 | $575,153 | 2024-04-03 |
| PALEKAR ROHAN | Derivatives Exercise | 25,000 | 2024-04-03 | ||
| RA CAPITAL MANAGEMENT, L.P. | Open Market Purchase | 1,350,000 | $15.35 | 2024-03-06 | |
| PALEKAR ROHAN | Sale | -4,477 | $10.76 | $48,173 | 2024-02-28 |
| Martins Ryan | Sale | -778 | $9.74 | $7,578 | 2024-02-23 |
| PALEKAR ROHAN | Sale | -4,602 | $9.74 | $44,823 | 2024-02-23 |
| Le-Nguyen Quoc | Sale | -1,046 | $9.74 | $10,188 | 2024-02-23 |
| Mansbach Harry H | Sale | -1,046 | $9.74 | $10,188 | 2024-02-23 |
| Mansbach Harry H | Sale | -3,568 | $8.45 | $30,150 | 2024-02-13 |
| Martins Ryan | Sale | -3,568 | $8.45 | $30,150 | 2024-02-13 |
| Le-Nguyen Quoc | Sale | -3,568 | $8.45 | $30,150 | 2024-02-13 |
| PALEKAR ROHAN | Sale | -12,670 | $8.45 | $107,061 | 2024-02-13 |
| PALEKAR ROHAN | Sale | -5,068 | $9.8 | $49,666 | 2024-02-05 |
| PALEKAR ROHAN | Grant, award...etc | 150,000 | 2024-02-05 | ||
| Martins Ryan | Sale | -892 | $9.8 | $8,742 | 2024-02-05 |
| Martins Ryan | Grant, award...etc | 48,750 | 2024-02-05 | ||
| Le-Nguyen Quoc | Sale | -1,190 | $9.8 | $11,662 | 2024-02-05 |
| Le-Nguyen Quoc | Grant, award...etc | 48,750 | 2024-02-05 | ||
| Mansbach Harry H | Sale | -1,190 | $9.8 | $11,662 | 2024-02-05 |
| Mansbach Harry H | Grant, award...etc | 48,750 | 2024-02-05 | ||
| PALEKAR ROHAN | Sale | -27,511 | $11.53 | $317,202 | 2024-01-08 |
| PALEKAR ROHAN | Grant, award...etc | 75,000 | 2024-01-08 | ||
| Le-Nguyen Quoc | Sale | -9,671 | $11.53 | $111,507 | 2024-01-08 |
| Le-Nguyen Quoc | Grant, award...etc | 25,000 | 2024-01-08 | ||
| Martins Ryan | Sale | -6,124 | $11.53 | $70,610 | 2024-01-08 |
| Martins Ryan | Grant, award...etc | 15,000 | 2024-01-08 | ||
| Mansbach Harry H | Sale | -9,671 | $11.53 | $111,507 | 2024-01-08 |
| Mansbach Harry H | Grant, award...etc | 25,000 | 2024-01-08 | ||
| PALEKAR ROHAN | Sale | -50,000 | $11.2 | $560,000 | 2024-01-03 |
| PALEKAR ROHAN | Derivatives Exercise | 50,000 | 2024-01-03 | ||
| Mansbach Harry H | Sale | -3,821 | $16.61 | $63,467 | 2023-09-12 |
| Martins Ryan | Sale | -2,074 | $16.61 | $34,449 | 2023-09-12 |
| Le-Nguyen Quoc | Sale | -4,958 | $16.61 | $82,352 | 2023-09-12 |
| Le-Nguyen Quoc | Sale | -1,591 | $15.64 | $24,883 | 2023-08-21 |
| Mansbach Harry H | Sale | -1,591 | $15.64 | $24,883 | 2023-08-21 |
| PALEKAR ROHAN | Sale | -4,501 | $15.46 | $69,585 | 2023-08-21 |
| Martins Ryan | Sale | -1,099 | $15.64 | $17,188 | 2023-08-21 |
| LAPORTE KATHLEEN | Sale | -12,500 | $18.8 | $235,000 | 2023-07-18 |
| LAPORTE KATHLEEN | Derivatives Exercise | 12,500 | 2023-07-18 | ||
| Mansbach Harry H | Sale | -2,882 | $18.95 | $54,614 | 2023-07-05 |
| Mansbach Harry H | Grant, award...etc | 8,334 | 2023-07-05 | ||
| Le-Nguyen Quoc | Sale | -2,882 | $18.95 | $54,614 | 2023-07-05 |
| Le-Nguyen Quoc | Grant, award...etc | 8,334 | 2023-07-05 | ||
| PALEKAR ROHAN | Sale | -16,527 | $18.95 | $313,187 | 2023-07-05 |
| PALEKAR ROHAN | Grant, award...etc | 33,334 | 2023-07-05 | ||
| Martins Ryan | Sale | -2,018 | $18.95 | $38,241 | 2023-07-05 |
| Martins Ryan | Grant, award...etc | 5,834 | 2023-07-05 |
The information provided in this report about ETNB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
89bio, Inc(NASDAQ:ETNB) 
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalc...
Website: http://www.89bio.com
Founded: 2018
IPO Price: $16 (Nov 11, 2019)
Full Time Employees: 25
CEO: Rohan Palekar
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends